Aldesleukin
- TRADE NAMES: Aerovent; Atem; Atronase; Narilet; Proleukin (Chiron)
- INDICATIONS: Metastatic renal cell carcinoma and metastatic melanoma
- SYNONYM: IL-2; interleukin-2
- CLASS: Biologic, Immunomodulator, Interleukin-2
- HALF-LIFE: 6–85 minutes
Acebutolol, Alfuzosin, Altretamine, Amikacin, Aminoglycosides, Antineoplastics, Betamethasone, Bleomycin, Busulfan, Captopril, Carboplatin, Carmustine, Chlorambucil, Ciclesonide, Cilazapril, Cisplatin, Corticosteroids, Cyclophosphamide, Cytarabine, Dacarbazine, Dactinomycin, Daunorubicin, Docetaxel, Doxorubicin, Enalapril, Estramustine, Etoposide, Fludarabine, Fluorouracil, Fosinopril, Gemcitabine, Gentamicin, Hydroxyurea, Idarubicin, Ifosfamide, Indomethacin, Interferon Alfa, Irbesartan, Kanamycin, Levamisole, Lisinopril, Lomustine, Mechlorethamine, Melphalan, Mercaptopurine, Methotrexate, Mitomycin, Mitotane, Mitoxantrone, Neomycin, Olmesartan, PEG-Interferon, Pentostatin, Plicamycin, Procarbazine, Quinapril, Ramipril, Streptomycin, Streptozocin, Thioguanine, Thiotepa, Tobramycin, Trandolapril, Tretinoin, Triamcinolone, Uracil, Vinblastine, Vincristine, Vinorelbine
PREGNANCY CATEGORY: C
Contra-indicated in patients with significant cardiac, pulmonary, renal, hepatic, or CNS impairment.
See full prescribing information for complete boxed warning.
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
